Patents by Inventor Adrian Fisher

Adrian Fisher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240135558
    Abstract: Z maps combined with a standardized stimulus in the form of a targeted arterial partial pressures of carbon dioxide provide suprisingly enhanced images for the assessment of pathological CVR. For example, the z-map assessment of patients with known steno-occlusive diseases of the cervico-cerebral vasculature showed an enhanced resolution of the presence, localization, and severity of the pathological CVR. Z-map have been found to be useful to reduce the confounding effects of test-to-test, subject-to-subject, and platform-to-platform variability for comparison of CVR images showing the importance of combining this analysis with the standardized stimulus.
    Type: Application
    Filed: December 15, 2023
    Publication date: April 25, 2024
    Inventors: Joseph FISHER, Olivia SOBCZYK, Adrian P. CRAWLEY, Julien POUBLANC, Kevin SAM, Daniel M. MANDELL, David MIKULIS, James DUFFIN
  • Publication number: 20240102774
    Abstract: An Antenna Positioning System for missile seeker and system development and test comprises an antenna module, and a plurality of tethers, wherein the antenna module is suspended in a position by the tethers and the position is capable of being changed and the antenna module manoeuvred by pulling at least one tether and simultaneously releasing at least one tether. The system is useful for testing and developing Radio Frequency (RF) missile technology in a controlled, simulated environment rather than by live missile firings.
    Type: Application
    Filed: December 15, 2021
    Publication date: March 28, 2024
    Inventors: Adrian Rumble, Kevin Fisher
  • Publication number: 20210302935
    Abstract: A plurality of system control devices respectively include network interfaces for communicating with each other via a network. One of the plurality of system control devices functions as a master system control device, and the remaining system control devices function as slave system control devices. The master system control device transmits a control command to the slave system control devices by means of the network interface. The slave system control devices receive the control command by means of the network interfaces and supply an operation command to abatement devices in accordance with the control command. When unable to communicate with the master system control device, the slave system control devices either function as master system control devices or enter stand-alone operation mode.
    Type: Application
    Filed: August 5, 2019
    Publication date: September 30, 2021
    Inventors: Kobayashi Kenichiro, Adrian Fisher, Christopher Peter Jones, Philip Carr
  • Patent number: 8352795
    Abstract: A method of ensuring high integrity of a processor is provided. The method includes executing sets of sequential instructions, each execution being based on a unique initial value, generating a computed final value responsive to each execution of a set of sequential instructions, and sending computed values to a monitoring portion of a high integrity processor monitor system responsive to the generating for each execution of the set of sequential instructions. The execution of the sets of sequential instructions tests pertinent addressing modes, operand sizes, and instruction side-effects for each instruction tested in a monitored central processing unit.
    Type: Grant
    Filed: February 11, 2009
    Date of Patent: January 8, 2013
    Assignee: Honeywell International Inc.
    Inventors: Larry James Miller, Paul Adrian Fisher, Robert J. Quirk
  • Publication number: 20120142646
    Abstract: The present invention provides compounds of formula (I) wherein k, Ar, R2, R3, R4, R5, R4?, R5?, R6, R7, A, D, m and E are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: December 19, 2007
    Publication date: June 7, 2012
    Inventors: Lilian Alcaraz, Roger Victor Bonnert, Stephen Connolly, Anthony Ronald Cook, Adrian Fisher, Alexander Humphries, Piotr Raubo
  • Publication number: 20100205414
    Abstract: A method of ensuring high integrity of a processor is provided. The method includes executing sets of sequential instructions, each execution being based on a unique initial value, generating a computed final value responsive to each execution of a set of sequential instructions, and sending computed values to a monitoring portion of a high integrity processor monitor system responsive to the generating for each execution of the set of sequential instructions. The execution of the sets of sequential instructions tests pertinent addressing modes, operand sizes, and instruction side-effects for each instruction tested in a monitored central processing unit.
    Type: Application
    Filed: February 11, 2009
    Publication date: August 12, 2010
    Applicant: HONEYWELL INTERNATIONAL INC.
    Inventors: Larry James Miller, Paul Adrian Fisher, Robert J. Quirk
  • Publication number: 20100144606
    Abstract: The invention provides a pharmaceutical product, kit or composition comprising a first active ingredient which is N-Cyclohexyl-N3-[2-(3-fluorophenyl)ethyl]-N-(2-{[2-(4-hydroxy-2-oxo-2,3-dihydro-1,3-benzothiazol-7-yl)ethyl]amino}ethyl)-?-alaninamide or a salt thereof, and a second active ingredient selected from: a non-steroidal Glucocorticoid Receptor (GR Receptor) Agonist; an antioxidant; a CCR1 antagonist; a chemokine antagonist (not CCR1); a corticosteroid; a CRTh2 antagonist; a DP1 antagonist; an Histone Deacetylase Inducer; an IKK2 inhibitor; a COX inhibitor; a lipoxygenase inhibitor; a leukotriene receptor antagonist; an MPO inhibitor; a muscarinic antagonist; a p38 inhibitor; a PDE inhibitor; a PPAR? agonist; a protease inhibitor; a Statin; a thromboxane antagonist; a vasodilator; or, an ENAC blocker (Epithelial Sodium-channel blocker); and its use in the treatment of respiratory disease (for example chronic obstructive pulmonary disease (COPD) or asthma); to certain salts of N-Cyclohexyl-N3-[2-(3-fluo
    Type: Application
    Filed: June 19, 2009
    Publication date: June 10, 2010
    Applicant: AstraZeneca AB
    Inventors: Stephen Connolly, Adrian Fisher, Alexander Humphries, Andrew Watts, Katherine Wiley
  • Publication number: 20100056508
    Abstract: The present invention provides compounds of formula (I), wherein k, Ar, R2, R3, R4, R5, R4?, R5?, R6, R7, A, D, m and E are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: December 19, 2007
    Publication date: March 4, 2010
    Applicant: ASTRAZENECA AB
    Inventors: Lilian Alcaraz, Roger Victor Bonnert, Stephen Connolly, Anthony Ronald Cook, Adrian Fisher, Alexander Humphries, Piotr Raubo
  • Patent number: 6309716
    Abstract: Sets of tessellatable elements are disclosed, in which a relatively low number of different elements may be combined together to provide very attractive tessellating patterns. The elements may be in the form of tiles, for paving or for covering flooring or walls, for example, game pieces, including television and computer games, pieces for use in maze construction and for many other applications.
    Type: Grant
    Filed: September 24, 1999
    Date of Patent: October 30, 2001
    Inventors: Adrian Fisher, Edward Taylor Pegg, Jr.
  • Patent number: 5945181
    Abstract: Sets of tessellatable polygonal elements are provided from which a variety of tessellations may be formed for a variety of applications, e.g., to provide coverings and decorations for surfaces such as pedestrian walks, driveways, floors and walls, and to provide patterns for games, puzzles and coloring books. Several different embodiments, applications and tessellations are described. In one embodiment, irregular heptagonal elements are tessellated with substantially regular pentagonal elements. In another embodiment, the elements are heptagonal and square. The tessellations may have straight edges by providing one or more elements of the set of tessellatable elements with a line of symmetry and providing a further tessellatable element or elements which is that part of the element on either side of the line of symmetry. The elements may be colored to provide many variations and decorations.
    Type: Grant
    Filed: October 11, 1996
    Date of Patent: August 31, 1999
    Inventor: Adrian Fisher
  • Patent number: D823240
    Type: Grant
    Filed: November 8, 2016
    Date of Patent: July 17, 2018
    Assignee: Clarius Mobile Health Corp.
    Inventors: Binda Zhang, Ryan Lee, Adrian Fisher